Clinical Trial Update: A Safety and Efficacy Study of the Dynalink®-E Everolimus Eluting Peripheral Stent System [NA]

View source ↗

Summary

This completed clinical trial evaluated the safety and efficacy of the Dynalink-E Everolimus-eluting peripheral stent system for patients with atherosclerosis a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Peripheral Vascular Disease

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: Abbott Medical Devices | Conditions: Atherosclerosis, Peripheral Vascular Disease | NA | Status: COMPLETED